P21.13 Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program

التفاصيل البيبلوغرافية
العنوان: P21.13 Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program
المؤلفون: F. Tsou, C. Pupareli, B. Bustos, G. Ferreira, J.N. Minatta, G. Roa, C. Novas, M.V. Bluthgen, D. Gomez Bradley, M. Flores, C. Martin, C. Gabay, Eduardo Richardet, Manglio Rizzo, M. Angel, M. Bonet, C. Caglevic, M. Paskevicius, J. Cundom, M. Tatangelo, F. Reinhold, R. Kowalyszyn, A. Pini
المصدر: Journal of Thoracic Oncology. 16:S369
بيانات النشر: Elsevier BV, 2021.
سنة النشر: 2021
مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Durvalumab, Oncology, business.industry, medicine, Locally advanced, Medical physics, business, Real world data
تدمد: 1556-0864
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9800488384b1c9e89347a8c4882a6f90
https://doi.org/10.1016/j.jtho.2021.01.593
حقوق: OPEN
رقم الأكسشن: edsair.doi...........9800488384b1c9e89347a8c4882a6f90
قاعدة البيانات: OpenAIRE